Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
9,929,185
-
Share change
-
+583,025
-
Total reported value
-
$12,511,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.26
-
Number of holders
-
34
-
Value change
-
+$612,639
-
Number of buys
-
10
-
Number of sells
-
15
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2016
As of 31 Mar 2016,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,929,185 shares.
The largest 10 holders included
Vivo Capital, LLC, Frigate Ventures LP, VANGUARD GROUP INC, Ancora Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., Connor, Clark & Lunn Investment Management Ltd., BRIDGEWAY CAPITAL MANAGEMENT INC, FMR LLC, and WASATCH ADVISORS INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.